At the Special Meeting of Stockholders held on December 5, 2025, the Company's stockholders approved a reverse stock split of ...

Last week, Insight Molecular Diagnostics Inc. ( NASDAQ:IMDX ) insiders, who had purchased shares in the previous ...

In this interview, Dr. Denise Heaney discusses how molecular diagnostics are reshaping antimicrobial stewardship and ...

Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented ...

MIAMI, FL / / December 17, 2025 / KIFFIK Biomedical announced today the successful close of its Series A financing, ...

Korea's first fully automated diagnostic system capable of simultaneously detecting 16 major foodborne pathogens within one ...

Next-gen diagnostics: Advances in molecular platforms, informatics and AI enable smarter, more personalized care. Innovation at scale: R&D strategies are shaping diagnostics to meet global healthcare ...

Co-Diagnostics ( ($CODX) ) just unveiled an update. On December 5, 2025, Co-Diagnostics’ stockholders approved a reverse stock split ...

The Southern blot, which detects specific DNA sequences, was one of the first molecular diagnostic methods to be widely adopted. 2 This type of probe-based assay uses a single-stranded oligonucleotide ...

IMDX is trading in the middle of its 52-week range and above its 200-day simple moving average. Price change The price of IMDX shares has decreased $0.34 since the market last closed. This is a 6.09% ...

Liv Hospital integrates PET/CT diagnostics, radionuclide therapies and a multidisciplinary council to create individualized treatment plans for complex cancer and cardiac cases.

Co-Diagnostics receives Australian patent covering Co-Dx PCR platform technologies for nucleic acid detection and analysis: Salt Lake City Wednesday, December 31, 2025, 11:00 Hrs ...